Best Fit Profiles
- triglyceride management, cardiovascular protection, and anti-inflammatory baseline support
Inflammation resolution and cardiovascular health
Omega-3 Fatty Acids
EPA and DHA omega-3 fatty acids have robust evidence for triglyceride reduction, cardiovascular risk in high-risk populations (REDUCE-IT), anti-inflammatory effects, and brain support. VITAL trial showed modest benefit in non-high-risk populations.
Evidence Level A
Evidence and Risk Labels
Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.
See full scoring guideClinical Snapshot
- Effect Size
- Large triglyceride reduction; moderate cardiovascular risk reduction in high-risk individuals; modest anti-inflammatory effect
- Safety
- Low Risk
High doses (>3 g EPA+DHA) can increase bleeding time; fish-sourced oils may contain contaminants — choose third-party tested brands.
Research Dosing
This reflects common ranges and protocols used in published studies, not personal medical advice.
- Typical Daily Dose
- 1-4 g EPA+DHA
- Timing
- With meals to improve absorption and reduce fishy aftertaste
- Protocol Duration in Studies
- Long-term for cardiovascular and anti-inflammatory effects
EPA:DHA ratio matters for specific outcomes (EPA-dominant for cardiovascular; DHA-dominant for brain).